Published in Oncotarget on June 20, 2015
Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med (2013) 1.54
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients. J Clin Invest (2009) 1.19
Heme oxygenase-1: emerging target of cancer therapy. J Biomed Sci (2015) 1.03
The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes. Immunobiology (2013) 0.92
Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients. BMC Cancer (2013) 0.92
Heme oxygenase-1 in pregnancy and cancer: similarities in cellular invasion, cytoprotection, angiogenesis, and immunomodulation. Front Pharmacol (2015) 0.90
Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulation. J Clin Invest (2015) 0.86